【远大医药(00512.HK)引进全球创新的治疗蠕形螨睑缘炎及蠕形螨导致的睑板腺功能障碍产品】智通财经APP讯，远大医药(00512.

智通财经03-27

【远大医药(00512.HK)引进全球创新的治疗蠕形螨睑缘炎及蠕形螨导致的睑板腺功能障碍产品】智通财经APP讯，远大医药(00512.HK)发布公告，集团与联拓生物科技有限公司和Tarsus Pharmaceuticals, Inc.(Tarsus)达成产品引进战略合作协议。在相关条件获得满足后，集团将以1500万美元的首付款及一定金额的注册里程碑费用为代价取得用于治疗蠕形螨睑缘炎及蠕形螨导致...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2422504329?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-27 17:30","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2422504329","market":"us","top_or_hot":-1,"title":"【远大医药(00512.HK)引进全球创新的治疗蠕形螨睑缘炎及蠕形螨导致的睑板腺功能障碍产品】智通财经APP讯，远大医药(00512.","media":"智通财经","content":"<div>\n<p>【远大医药(00512.HK)引进全球创新的治疗蠕形螨睑缘炎及蠕形螨导致的睑板腺功能障碍产品】智通财经APP讯，远大医药(00512.HK)发布公告，集团与联拓生物科技有限公司和Tarsus Pharmaceuticals, \n\nInc.(Tarsus)达成产品引进战略合作协议。在相关条件获得满足后，集团将以1500万美元的首付款及一定金额的注册里程碑费用为代价取得用于治疗蠕形螨睑缘炎及蠕形螨导致...</p>\n\n<a href=\"https://www.zhitongcaijing.com/immediately.html?type=ganggu\">网页链接</a>\n\n</div>\n","source":"live_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7x24快讯</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7x24快讯\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-27 17:30 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.zhitongcaijing.com/immediately.html?type=ganggu><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>【远大医药(00512.HK)引进全球创新的治疗蠕形螨睑缘炎及蠕形螨导致的睑板腺功能障碍产品】智通财经APP讯，远大医药(00512.HK)发布公告，集团与联拓生物科技有限公司和Tarsus Pharmaceuticals, \n\nInc.(Tarsus)达成产品引进战略合作协议。在相关条件获得满足后，集团将以1500万美元的首付款及一定金额的注册里程碑费用为代价取得用于治疗蠕形螨睑缘炎及蠕形螨导致...</p>\n\n<a href=\"https://www.zhitongcaijing.com/immediately.html?type=ganggu\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LIAN","symbol_name":"联拓生物","start_time":0,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","article_id":"2422504329","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2422504329","pubTimestamp":1711531853,"sourceInfo":{"source_id":"live_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"【远大医药(00512.HK)引进全球创新的治疗蠕形螨睑缘炎及蠕形螨导致的睑板腺功能障碍产品】智通财经APP讯，远大医药(00512.HK)发布公告，集团与联拓生物科技有限公司和Tarsus Phar","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LIAN":"联拓生物","BK1191":"制药","BK4139":"生物科技","TARS":"Tarsus Pharmaceuticals, Inc.","00512":"远大医药","BK4007":"制药"},"translate_title":"[Grand Pharmaceutical (00512. HK) introduces globally innovative products for the treatment of Demodex blepharitis and meibomian gland dysfunction caused by Demodex mites] Zhitong Finance APP News, Grand Pharmaceutical (00512.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00512":1,"LIAN":1,"TARS":1},"content_text":"【远大医药(00512.HK)引进全球创新的治疗蠕形螨睑缘炎及蠕形螨导致的睑板腺功能障碍产品】智通财经APP讯，远大医药(00512.HK)发布公告，集团与联拓生物科技有限公司和Tarsus Pharmaceuticals, \n\nInc.(Tarsus)达成产品引进战略合作协议。在相关条件获得满足后，集团将以1500万美元的首付款及一定金额的注册里程碑费用为代价取得用于治疗蠕形螨睑缘炎及蠕形螨导致的睑板腺功能障碍的全球创新眼用制剂TP-03在大中华区(中国大陆、中国香港特别行政区、中国澳门特别行政区、台湾地区)的独家开发、生产及商业化权益。此次战略合作将深化集团在眼科领域的产品布局。","kind":null,"is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2422504329"}